INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 455m ago
HOUSE PTR55m ago
SEC 13F54m ago
ROBINHOOD CHAIN54m ago
Public company

Perspective Therapeutics, Inc.

CATXCIK 0000728387

EDGAR filingsOpen in network
Price$0.84
1 year-63.9%
Disclosed transactions7
Buys / sells0 / 7
Max Insider Score35
Connections with evidence3

CATX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
28
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$526K
167.1K sh
Sep 4, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Lantheus Alpha Therapy, LLC10% Owner · Sep 4, 2026
  • ← Insider ofevidence
    Lantheus Holdings, Inc.10% Owner · Sep 2, 2026
Sep 8, 2026
traded Sep 4, 2026
+4d
SEC FORM 4

Evidence

34
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$251K
80.8K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

31
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$112K
35.8K sh
Sep 1, 2026Sep 4, 2026
traded Sep 1, 2026
+3dSEC FORM 4

Evidence

35
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$246K
78.1K sh
Aug 31, 2026Sep 4, 2026
traded Aug 31, 2026
+4dSEC FORM 4

Evidence

25
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$131K
42.1K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC FORM 4

Evidence

25
Lantheus Holdings, Inc.10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$112K
35.8K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC FORM 4

Evidence

29
Lantheus Holdings, Inc.10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$246K
78.1K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC FORM 4

Evidence